Potential angiogenic biomarkers in hereditary hemorrhagic telangiectasia and other vascular diseases

In the world of precision and personalized medicine, biomarkers are emerging as crucial tools. A recent study delves into their potential, focusing on hereditary hemorrhagic telangiectasia (HHT), a rare genetic vascular disease with disruptions in angiogenic pathways. The study found that certain angiogenesis-related molecules exhibit distinct patterns in HHT patients compared to healthy individuals. These molecules hold promise for aiding in diagnosis, prognosis, complication prediction, and therapy monitoring in various vascular diseases. While more research is needed before clinical implementation, these molecules are promising biomarker candidates not only for HHT but also for other common vascular ailments.